Exhibit 8.1
| | | | |
| | 355 South Grand Avenue, Suite 100 |
| | Los Angeles, California 90071-1560 |
| | Tel: +1.213.485.1234 Fax: +1.213.891.8763 www.lw.com |
| |

March 30, 2020 | | FIRM / AFFILIATE OFFICES |
| Beijing | | Moscow |
| Boston | | Munich |
| Brussels | | New York |
| Century City | | Orange County |
| Chicago | | Paris |
| Dubai | | Riyadh |
| Düsseldorf | | San Diego |
| Frankfurt | | San Francisco |
| Hamburg | | Seoul |
| Hong Kong | | Shanghai |
| Houston | | Silicon Valley |
| London | | Singapore |
| Los Angeles | | Tokyo |
| Madrid | | Washington, D.C. |
| Milan | | |
Conatus Pharmaceuticals Inc., a Delaware corporation
16745 West Bernardo Dr., Suite 250
San Diego, CA 92127
| Re: | Agreement and Plan of Merger and Reorganization, dated as of January 28, 2020 |
Ladies and Gentlemen:
We have acted as special tax counsel to Conatus Pharmaceuticals Inc., a Delaware corporation (“Parent”), in connection with the proposed merger (the “Merger”) of Chinook Merger Sub, Inc., a Delaware corporation (“Merger Sub”) and wholly owned subsidiary of Parent, with and into Histogen, Inc., a Delaware corporation (the “Company”), with the Company surviving, as contemplated by the Agreement and Plan of Merger and Reorganization, dated as of January 28, 2020, by and among Parent, Merger Sub and Company (the “Merger Agreement”).
This opinion is being delivered in connection with the Registration Statement on FormS-4, including the proxy statement/prospectus/information statement forming a part thereof, initially filed by Parent on February 7, 2020 (as amended through the date hereof, the “Registration Statement”), relating to the transactions contemplated by the Merger Agreement. Capitalized terms not defined herein have the meanings specified in the Merger Agreement unless otherwise indicated.
In rendering our opinion, we have examined and, with your consent, are expressly relying upon (without any independent investigation or review thereof) the truth and accuracy of the factual statements, representations, covenants and warranties contained in (i) the Merger Agreement (including any Exhibits and Schedules thereto), (ii) the Registration Statement, (iii) the respective tax representation letters of Parent, Merger Sub and Company, each dated as of the date hereof and delivered to us for purposes of this opinion (the “Representation Letters”) and (iv) such other documents and corporate records as we have deemed necessary or appropriate for purposes of our opinion.